Thrombophilic risk factors in patients with central retinal vein occlusion

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 772-776

  Marcucci, R ^a   Bertini, L ^a   Giusti, B ^a   Brunelli, T ^a   Fedi, S ^a   Cellai, A P ^a   Poli, D ^a   Pepe, G ^a   Abbate, R ^a   Prisco, D ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Central retinal vein occlusion; Fibrinolysis; Genetic polymorphisms; Homocysteine; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENETIC POLYMORPHISM; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; VEIN THROMBOSIS;

EID: 0034852541     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616130     Document Type: Article

References (41)

1. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study
2. Central retinal vein occlusion in young adults (papillophlebitis)
3. Risk factors for retinal vein thrombosis: A case-control study
4. Does type II diabetes predispose to retinal vein occlusion?
5. Natural history and clinical management of central retinal vein occlusion
6. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion
7. Panretinal photocoagulation in central retinal vein occlusion: A randomized controlled clinical study
8. Role of rheologic factors in patients with acute central retinal vein occlusion
9. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors
10. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion
11. Protein C, protein S and antithrombin III in acute ocular occlusive diseases
12. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: A population controlled study
13. Activated protein C resistance in young adults with central retinal vein occlusion
14. Retinal vein occlusion and resistance to activated protein C
15. Activated protein C resistance, factor V Leiden and central retinal vein occlusion in young adults
16. Activated protein C resistance: Low incidence in glaucomatous disc hemorrhage and central retinal vein occlusion
17. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion
18. Prevalence of factor V Leiden in young adults with retinal vein occlusion
19. Markers of thrombophilia in retinal vein thrombosis
20. Retinal vein occlusion and inherited conditions predisposing to thrombophilia
21. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion
22. The 20210A allele of the prothrombin gene is not a risk factor for retinal vein occlusion
23. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism P1A2 in patients with central retinal vein occlusion
24. Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions
25. Antiphospholipid antibodies in retinal vascular occlusions: A prospective study of 75 patients
26. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
27. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
28. Hyperhomocysteinemia in retinal artery and retinal vein occlusion
29. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion
30. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease
31. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion
32. Thermolabile MTHFR genotype and retinal vascular occlusive disease
33. Hyperhomocysteinemia: A risk factor for central retinal vein occlusion
34. Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty
35. Lipoprotein (a) excess and coronary heart disease
36. Central retinal vein occlusion: What's the story?
37. Risk factors for central retinal vein occlusion
38. The high prevalence of high 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease
39. Serial measures of plasma homocysteine after acute myocardial infarction
40. Plasma homocysteine in the acute and convalescent phases after stroke
41. Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein (a) levels: A case-report